Abilify: Link to Compulsive Gambling
January 10, 2017 | Pharmaceutical Litigation
Abilify is one of the top-selling antipsychotic drugs in the United States and is often used to treat bipolar disorder, schizophrenia, and Tourette’s syndrome. However, the drug may be dangerous and lead to compulsive and risky behaviors. Many people who have taken Abilify have filed suit against the drug’s makers, Otsuka and Bristol-Myers Squibb, alleging that compulsive behaviors have led to physical and monetary harm. Compulsive behaviors linked to Abilify include excessive gambling, risky sexual behavior, and compulsive eating.
Your Right to File a Lawsuit
If you have taken Abilify and have become of a victim of Abilify’s compulsive side effects, leading to harm such as an STD, obesity or related disease, or serious gambling debts, you have the right to file a lawsuit. Bristol-Myers Squibb and Otsuka failed to warn consumers of the risks of compulsive behaviors when it marketed the drug. By filing a lawsuit and holding the companies liable for harm, you may be able to recover the value of your losses.
Work with Napoli Shkolnik PLLC
Working with an experienced pharmaceutical litigation attorney when pursuing a claim is within your best interest. At Napoli Shkolnik PLLC, we are proud to say that Partner Jennifer Liakos was appointed to the Plaintiffs’ Steering Committee in In Re: Abilify (Aripirazole) Products Liability Litigation. Our law firm handles a variety of pharmaceutical litigation cases, and our partners are often appointed to leadership roles in the multidistrict litigation cases we participate in.
We have the experience, skill set, and resources you are looking for. If Abilify has caused you harm, economic or otherwise, please contact us today for your free case consultation.